John Baldwin - SANTANDER Chief Banking
SANB Stock | 135.50 0.00 0.00% |
Executive
John Baldwin is Chief Banking of SANTANDER UK 8
Address | 2 Triton Square, London, United Kingdom, NW1 3AN |
Phone | 44 87 0607 6000 |
Web | https://www.santander.co.uk |
John Baldwin Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Baldwin against SANTANDER stock is an integral part of due diligence when investing in SANTANDER. John Baldwin insider activity provides valuable insight into whether SANTANDER is net buyers or sellers over its current business cycle. Note, SANTANDER insiders must abide by specific rules, including filing SEC forms every time they buy or sell SANTANDER'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Baldwin over three months ago Acquisition by John Baldwin of 8000 shares of Cleveland Cliffs at 14.53 subject to Rule 16b-3 | ||
John Baldwin over three months ago Acquisition by John Baldwin of 7500 shares of Cleveland Cliffs at 14.7029 subject to Rule 16b-3 |
SANTANDER Management Efficiency
At this time, SANTANDER's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 17.7 B in 2024, despite the fact that Other Current Assets are likely to grow to (4.7 B). SANTANDER's management efficiency ratios could be used to measure how well SANTANDER manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Shashi Kiran | Check Point Software | N/A | |
Scott MA | Target Healthcare REIT | N/A | |
FCA FCA | Target Healthcare REIT | N/A | |
Roei Golan | Check Point Software | N/A | |
Michael Marks | HCA Healthcare | 54 | |
Itai Greenberg | Check Point Software | N/A | |
Andrew Brown | Target Healthcare REIT | N/A | |
Terence Arkel | HCA Healthcare | N/A | |
Frdric Julien | Naturhouse Health SA | N/A | |
Jane Duran | CAP LEASE AVIATION | N/A | |
Kellie Davis | CAP LEASE AVIATION | N/A | |
Anita JD | PureTech Health plc | N/A | |
Allison Talbot | PureTech Health plc | N/A | |
Shira Yashar | Check Point Software | N/A | |
Martin Paslick | HCA Healthcare | 64 | |
Christopher Taylor | Young Cos Brewery | N/A | |
Jennifer Berres | HCA Healthcare | 53 | |
Joseph Bolen | PureTech Health plc | 70 | |
Kip Meintzer | Check Point Software | N/A | |
III JD | PureTech Health plc | N/A | |
Mark Kerkwijk | CAP LEASE AVIATION | N/A |
Management Performance
Return On Equity | 0.0924 | |||
Return On Asset | 0.0049 |
SANTANDER UK 8 Leadership Team
Elected by the shareholders, the SANTANDER's board of directors comprises two types of representatives: SANTANDER inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SANTANDER. The board's role is to monitor SANTANDER's management team and ensure that shareholders' interests are well served. SANTANDER's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SANTANDER's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brad Fordham, Head Mortgages | ||
Jennifer Scardino, Director Marketing | ||
Ben Covey, Head Banking | ||
Angel CFA, CFO Director | ||
Michael Bagguley, Head Markets | ||
Enrique Labiano, Chief Division | ||
Emma Leith, Chief Officer | ||
Adam Williams, Head Relations | ||
Angel Martell, CFO Director | ||
MA BA, Head Homes | ||
Paul Sharratt, Head Relations | ||
Colm Corcoran, Head Business | ||
Stewart Todd, Head Affairs | ||
Tracie Pearce, Chief Homes | ||
Madhukar Dayal, CFO Director | ||
John Baldwin, Chief Banking | ||
John Mills, Company Secretary | ||
MBA MBA, CEO Director | ||
Nick Peet, Divisional Finance |
SANTANDER Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SANTANDER a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0924 | |||
Return On Asset | 0.0049 | |||
Profit Margin | 0.29 % | |||
Operating Margin | 0.36 % | |||
Current Valuation | 45.19 B | |||
Shares Outstanding | 31.05 B | |||
Shares Owned By Institutions | 4.66 % | |||
Price To Sales | 9.08 X | |||
Revenue | 5.1 B | |||
Gross Profit | 4.64 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SANTANDER Stock Analysis
When running SANTANDER's price analysis, check to measure SANTANDER's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SANTANDER is operating at the current time. Most of SANTANDER's value examination focuses on studying past and present price action to predict the probability of SANTANDER's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SANTANDER's price. Additionally, you may evaluate how the addition of SANTANDER to your portfolios can decrease your overall portfolio volatility.